LVHN to remain in network with Aetna effective immediately.
LVHN permanecerá en la red de Aetna, efectivo inmediatamente.
Lehigh Valley Topper Cancer Institute is the largest cancer center in the region and sees more than 4,000 new patients every year. This volume gives us the experience to accurately diagnose cancer – even rare types for which the region may see just one case per year.
Some of the reasons referring providers send their patients to the Cancer Institute include:
We offer multidisciplinary clinics for many forms of cancer, including breast cancer and lung cancer. Patients see medical, radiation and surgical oncologists in one visit and leave with personalized care recommendations and a nurse navigator who assists them all along their cancer journey. Learn more about our multidisciplinary cancer clinics.
We participate in prestigious clinical trial networks, such as the National Cancer Institute’s Gynecologic Oncology Group. Read more about cancer research and clinical trials.
Our commitment to delivering high-quality cancer care is recognized at the national level. We have held the American Society of Clinical Oncology’s QOPI® designation since 2011. We also carry American College of Surgeons Commission on Cancer (CoC), American College of Radiology (ACR), National Accreditation Program for Breast Centers (NAPBC) and AAGL/SRC COEMIG accreditations and designations demonstrating our commitment to constantly measuring and improving outcomes.
Our expertise and treatment options lead to safer, more effective care. We are among the first programs in the country with a board-certified surgeon specializing in complex cancer procedures. The Cancer Institute was also the first cancer center in the region offering the Varian Edge™ radiosurgery system. Find out more about cancer treatments.
In the battle against cancer, you want every available weapon on your side. The Lehigh Valley Cancer Institute has joined the Memorial Sloan Kettering Cancer (MSK) Alliance to take the cancer fight to a new level.
Learn more